Literature DB >> 27568981

FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition.

J M Jeffery1, M Kalimutho1, P Johansson2, D G Cardenas1, R Kumar3, K K Khanna1.   

Abstract

F-box proteins in conjunction with Skp1, Cul1 and Rbx1 generate SCF complexes that are responsible for the ubiquitination of proteins, leading to their activation or degradation. Here we show that the F-box protein FBXO31 is required for normal mitotic progression and genome stability due to its role in regulating FOXM1 levels during the G2/M transition. FBXO31-depleted cells undergo a transient delay in mitosis due to an activated spindle checkpoint concomitant with an increase in lagging chromosomes and anaphase bridges. FBXO31 regulates mitosis in part by controlling the levels of FOXM1, a transcription factor and master regulator of mitosis. FBXO31 specifically interacts with FOXM1 during the G2/M transition, resulting in FOXM1 ubiquitination and degradation. FBXO31 depletion results in increased expression of FOXM1 transcriptional targets and mimics the FOXM1 overexpression. In contrast, co-depletion of FBXO31 and FOXM1 restores the genomic instability phenotype but not the delay in mitosis, indicating that FBXO31 probably has additional mitotic substrates. Thus, FBXO31 is the first described negative regulator of FOXM1 during the G2/M transition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27568981     DOI: 10.1038/onc.2016.268

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

Review 2.  Regulation of mRNA Translation during cellular division.

Authors:  Gilad Sivan; Orna Elroy-Stein
Journal:  Cell Cycle       Date:  2008-01-08       Impact factor: 4.534

3.  FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner.

Authors:  Jamila Laoukili; Monica Alvarez-Fernandez; Marie Stahl; René H Medema
Journal:  Cell Cycle       Date:  2008-09-10       Impact factor: 4.534

4.  Over-expression of FoxM1 stimulates cyclin B1 expression.

Authors:  T W Leung; S S Lin; A C Tsang; C S Tong; J C Ching; W Y Leung; R Gimlich; G G Wong; K M Yao
Journal:  FEBS Lett       Date:  2001-10-19       Impact factor: 4.124

Review 5.  Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer.

Authors:  Ceshi Chen; Arun K Seth; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2006-10       Impact factor: 5.852

6.  FBXO31 determines poor prognosis in esophageal squamous cell carcinoma.

Authors:  Ryunosuke Kogo; Koshi Mimori; Fumiaki Tanaka; Shizuo Komune; Masaki Mori
Journal:  Int J Oncol       Date:  2011-04-28       Impact factor: 5.650

7.  FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.

Authors:  Raman Kumar; Paul M Neilsen; Joanne Crawford; Ross McKirdy; Jaclyn Lee; Jason A Powell; Zarqa Saif; Julie M Martin; Marc Lombaerts; Cees J Cornelisse; Anne-Marie Cleton-Jansen; David F Callen
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

8.  Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.

Authors:  C Montero-Conde; J M Martín-Campos; E Lerma; G Gimenez; J L Martínez-Guitarte; N Combalía; D Montaner; X Matías-Guiu; J Dopazo; A de Leiva; M Robledo; D Mauricio
Journal:  Oncogene       Date:  2007-09-17       Impact factor: 9.867

9.  Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.

Authors:  Muy-Teck Teh; Emilios Gemenetzidis; Tracy Chaplin; Bryan D Young; Michael P Philpott
Journal:  Mol Cancer       Date:  2010-02-26       Impact factor: 27.401

10.  F-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20a.

Authors:  Xinchao Zhang; Ye Kong; Xia Xu; Huaixin Xing; Yingjie Zhang; Fengjuan Han; Wenjuan Li; Qing Yang; Jiping Zeng; Jihui Jia; Zhifang Liu
Journal:  Oncotarget       Date:  2014-08-15
View more
  14 in total

Review 1.  APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

Authors:  Morgan S Schrock; Benjamin R Stromberg; Luke Scarberry; Matthew K Summers
Journal:  Semin Cancer Biol       Date:  2020-03-09       Impact factor: 15.707

2.  The tumor suppressor FBXO31 preserves genomic integrity by regulating DNA replication and segregation through precise control of cyclin A levels.

Authors:  Parul Dutta; Sehbanul Islam; Srinadh Choppara; Pallabi Sengupta; Anil Kumar; Avinash Kumar; Mohan R Wani; Subhrangsu Chatterjee; Manas Kumar Santra
Journal:  J Biol Chem       Date:  2019-08-14       Impact factor: 5.157

3.  The SCFFBXO46 ubiquitin ligase complex mediates degradation of the tumor suppressor FBXO31 and thereby prevents premature cellular senescence.

Authors:  Srinadh Choppara; Sankaran Ganga; Rajeshkumar Manne; Parul Dutta; Shailza Singh; Manas Kumar Santra
Journal:  J Biol Chem       Date:  2018-08-31       Impact factor: 5.157

4.  FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression.

Authors:  Jinfeng Zhu; Jiefeng Zhao; Chen Luo; Zhengming Zhu; Xingyu Peng; Xiaojian Zhu; Kang Lin; Fanqin Bu; Wenjun Zhang; Qing Li; Kai Wang; Zhigang Hu; Xin Yu; Leifeng Chen; Rongfa Yuan
Journal:  Cell Death Dis       Date:  2022-05-25       Impact factor: 9.685

5.  Degradation of FBXO31 by APC/C is regulated by AKT- and ATM-mediated phosphorylation.

Authors:  Srinadh Choppara; Sunil K Malonia; Ganga Sankaran; Michael R Green; Manas Kumar Santra
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-17       Impact factor: 11.205

6.  Structural basis of the phosphorylation-independent recognition of cyclin D1 by the SCFFBXO31 ubiquitin ligase.

Authors:  Yunfeng Li; Kai Jin; Eric Bunker; Xiaojuan Zhang; Xuemei Luo; Xuedong Liu; Bing Hao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

Review 7.  FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.

Authors:  Cassie Liu; Carter J Barger; Adam R Karpf
Journal:  Cancers (Basel)       Date:  2021-06-19       Impact factor: 6.639

Review 8.  The role of F-box only protein 31 in cancer.

Authors:  Yuyong Tan; Deliang Liu; Jian Gong; Jia Liu; Jirong Huo
Journal:  Oncol Lett       Date:  2018-01-17       Impact factor: 2.967

Review 9.  The Dominant Role of Forkhead Box Proteins in Cancer.

Authors:  Duc-Hiep Bach; Nguyen Phuoc Long; Thi-Thu-Trang Luu; Nguyen Hoang Anh; Sung Won Kwon; Sang Kook Lee
Journal:  Int J Mol Sci       Date:  2018-10-22       Impact factor: 5.923

Review 10.  Regulation of the master regulator FOXM1 in cancer.

Authors:  Guo-Bin Liao; Xin-Zhe Li; Shuo Zeng; Cheng Liu; Shi-Ming Yang; Li Yang; Chang-Jiang Hu; Jian-Ying Bai
Journal:  Cell Commun Signal       Date:  2018-09-12       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.